Grand Central Investment Group’s AbbVie ABBV Stock Holding History

Grand Central Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75M	Sell	6,950 -37	-0.5%	-$7.96K	1.46%	25
2026 Q1	$1.52M	Sell	6,987 -42	-0.6%	-$9.32K	1.12%	25
2025 Q4	$1.61M	Buy	+7,029	New	+$1.6M	1.17%	26
2022 Q3	$1.05M	Buy	7,849 +33	+0.4%	+$4.74K	1.47%	16
2022 Q2	$1.2M	Sell	7,816 -456	-6%	-$69.7K	1.72%	16
2022 Q1	$1.34M	Sell	8,272 -100	-1%	-$14.5K	1.59%	18
2021 Q4	$1.13M	Sell	8,372 -510	-6%	-$60.2K	1.36%	17
2021 Q3	$958K	Sell	8,882 -1,354	-13%	-$155K	1.27%	19
2021 Q2	$1.15M	Buy	10,236 +425	+4%	+$47.9K	1.03%	20
2021 Q1	$1.06M	Buy	9,811 +218	+2%	+$23.3K	1.03%	20
2020 Q4	$1.03M	Buy	+9,593	New	+$922K	0.92%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Grand Central Investment Group's ABBV Position: Q2 2026 in Review

Grand Central Investment Group reduced its AbbVie (ABBV) stake by 0.53% in Q2 2026, selling an estimated $7.96K and leaving 6,950 shares worth $1.75M. The position accounts for 1.46% of the portfolio, ranked #25.

Grand Central Investment Group first reported a position in ABBV in Q4 2020 and has held it in 11 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Grand Central Investment Group held 6,950 shares of AbbVie worth $1.75M as of Q2 2026.
Grand Central Investment Group sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
AbbVie made up 1.46% of Grand Central Investment Group's portfolio in Q2 2026, its #25 holding.
Grand Central Investment Group first reported a position in AbbVie in Q4 2020 and has held it in 11 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Grand Central Investment Group's 13F filing for Q2 2026, filed 4 Aug 2026.